https://scholars.lib.ntu.edu.tw/entities/project/6237771c-d0ec-4782-943a-d787d075eaf7
Study of Rosiglitazone-Induced Apoptosis in Human Anaplastic Thyroid Cancer Cells
anaplastic thyroid cancerin humanstudyrosiglitazoneinduced
https://pubmed.ncbi.nlm.nih.gov/39593172/
YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4/AKT/mTOR signaling...
This study is the first to demonstrate that elevated YTHDF2 expression levels suppress DDIT4 expression in an m6A-dependent manner and activate the AKT/mTOR...
anaplastic thyroid cancer
https://adisinsight.springer.com/trials/700366539?error=cookies_not_supported&code=d2dd3ee7-797e-40f5-8230-ce73cef0a974
A Phase 1 Study of THRV-1257 in Anaplastic Thyroid Cancer - AdisInsight
The first in human study will determine the optimal dosing of THRV-1257 in patients with solid tumors, followed by treatment in combination with approved cancer
anaplastic thyroid cancer
https://scholars.lib.ntu.edu.tw/entities/publication/74244416-3459-4a3e-b3f9-50a6dc6ba8e8
Immunotherapy in anaplastic thyroid cancer: Case series
Unresectable anaplastic thyroid cancer (ATC) has a poor prognosis. Chemotherapy and radiotherapy have limited effects on it. Here, we present four cases who...
anaplastic thyroid cancerimmunotherapycaseseries
https://ja.dh.duke.edu/endocrine_grandrounds/session-topic-be-announced-later-318
Hope for Anaplastic Thyroid Cancer? Results of the FACT Trial | DUKEHealth JA
anaplastic thyroid cancer
https://pubmed.ncbi.nlm.nih.gov/35026411/
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated...
These updated results confirm the substantial clinical benefit and manageable toxicity of dabrafenib plus trametinib in BRAF V600E-mutant ATC. Dabrafenib plus...
https://scholars.lib.ntu.edu.tw/entities/publication/71413361-9b0a-4c17-99fe-0a2cf7503d11
The impact of BRAF targeting agents in advanced anaplastic thyroid cancer: a multi-institutional...
Anaplastic thyroid cancer (ATC) is a rare but lethal thyroid cancer. Dabrafenib and trametinib has been the standard treatment for the patients with BRAF...